1205 Amber Drive
Thunder Bay, ON P7B 6M4
Industry: Medical Instruments & Supplies
|Dr. Francis Dube B.Sc.||Exec. Chairman||183.33k||N/A||N/A|
|Mr. Gregory Fenton C.F.A.||CEO & Director||200k||N/A||N/A|
|Mr. Brian Bosse B.A., C.F.A.||COO & Director||106.67k||N/A||1973|
|Ms. Wendy Ford CA, CPA||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Colin van der Kuur B.Sc., DMIN||VP of Science & Research||N/A||N/A||N/A|
|Mr. Ryan Shacklock||VP of Strategy, Bus. Devel. & Investor Relations||N/A||N/A||N/A|
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Zentek Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.